Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rho GTPase-dependent transformation by G protein-coupled receptors.

I P Whitehead1, I E Zohn, C J Der

  • 1Department of Microbiology and Molecular Genetics, UMDNJ-New Jersey Medical School, Newark, New Jersey, NJ 07103-2714, USA.

Oncogene
|April 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease.

Oncogene·2013
Same author

Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity.

Blood cancer journal·2013
Same author

Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression.

Leukemia·2012
Same author

Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling.

Oncogene·2009
Same author

Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility.

Cancer metastasis reviews·2009
Same author

p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.

Oncogene·2009

Certain G protein-coupled receptors (GPCRs) can drive cancer development. These GPCR oncoproteins activate specific cellular pathways, leading to uncontrolled cell growth and tumor formation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • G protein-coupled receptors (GPCRs) are a vast family of cell surface receptors involved in signal transduction.
  • While typically regulating metabolism in differentiated cells, some GPCRs are implicated in cell proliferation and oncogenesis.
  • Activating mutations and overexpression of GPCRs are linked to human tumors.

Purpose of the Study:

  • To review the signaling and transforming properties of GPCR oncoproteins.
  • To highlight the role of specific GPCRs (Mas, G2A, PAR-1) in oncogenic transformation.
  • To elucidate the molecular mechanisms underlying GPCR-mediated oncogenesis.

Main Methods:

  • Review of existing literature on GPCRs, oncogenes, and cell signaling.
  • Analysis of expression screening data identifying transforming GPCRs.

Related Experiment Videos

  • Summary of studies investigating GPCR signaling pathways and their link to cancer.

    • Main Results:

    • GPCRs, including Mas, G2A, and PAR-1, can induce oncogenic transformation of cells.
    • These transforming GPCRs activate Rho family small GTPases.
    • Aberrant activation of these GTPases leads to dysregulated cell growth.

    Conclusions:

    • GPCRs represent a significant class of oncoproteins.
    • GPCR-mediated oncogenesis involves the activation of specific GTPase signaling cascades.
    • Targeting these pathways may offer therapeutic strategies for GPCR-driven cancers.